Home › Funds › Karpus Management, Inc. › DMII

Karpus Management, Inc. position in DMII

DRUGS MADE IN AMERICA ACQ CRP II; TNT ACQ DT: 9/25/2027; CASH: $10.00 · Financials

Karpus Management, Inc. reported holding 3,300,023 shares of DMII (DRUGS MADE IN AMERICA ACQ CRP II; TNT ACQ DT: 9/25/2027; CASH: $10.00) in its Q3 2026 13F filing — a position valued at US$33.6M, representing 1.02% of its reported portfolio and ranking #23 among its reported holdings. Karpus Management, Inc. has disclosed DMII holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)3.30M sh
Reported value held$33.59M
Portfolio Weight1.02%
First reportedQ4 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Karpus Management, Inc.'s DMII position evolved

Karpus Management, Inc. first disclosed a stake in DMII in Q4 2025 at 1,143,625 shares (US$11.3M). The position peaked in Q3 2026 at 3,300,023 shares, worth US$33.6M. Across 4 filings, Karpus Management, Inc. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,300,023 shares valued at US$33.6M — an increase of 512,025 shares quarter over quarter.. Notable position changes include a 127% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.14M $11.32M New
Q1 2026 2.60M $25.90M Add
Q2 2026 2.79M $28.05M Add
Q3 2026 3.30M $33.59M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DMII and 13F data

DMII (DRUGS MADE IN AMERICA ACQ CRP II; TNT ACQ DT: 9/25/2027; CASH: $10.00) is a Financials company. 69 other funds we track also report a position in DMII — the largest reported positions include Magnetar Financial LLC (US$27.5M), MMCAP International Inc. SPC (US$27.5M), GLAZER CAPITAL, LLC (US$23.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DMII

All DMII fund holders →

FAQ

How long has Karpus Management, Inc. held DMII?

Karpus Management, Inc. has disclosed DMII holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Karpus Management, Inc.'s current position in DMII?

As of Q3 2026, Karpus Management, Inc. holds 3.30M shares of DMII (DRUGS MADE IN AMERICA ACQ CRP II; TNT ACQ DT: 9/25/2027; CASH: $10.00), valued at $33.59M, representing 1.02% of its reported portfolio and ranking #23.

Has Karpus Management, Inc. been buying or selling DMII?

In the latest 13F filing (Q3 2026), Karpus Management, Inc. increased its position in DMII. The position peaked in Q3 2026 at 3.30M shares.

Which other funds hold DMII?

Other major institutional holders of DMII include Magnetar Financial LLC, MMCAP International Inc. SPC, GLAZER CAPITAL, LLC, among 69 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.